0002085092-26-000002.txt : 20261013 0002085092-26-000002.hdr.sgml : 20261013 20261013110345 ACCESSION NUMBER: 0002085092-26-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20261013 DATE AS OF CHANGE: 20261013 EFFECTIVENESS DATE: 20261013 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Janus Henderson Biotech Innovation Fund II Access LLC CENTRAL INDEX KEY: 0002085092 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-557611 FILM NUMBER: 261455712 BUSINESS ADDRESS: STREET 1: ICAPITAL ALTERNATIVE INVESTMENTS LLC STREET 2: 60 EAST 42ND STREET, 26TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10165 BUSINESS PHONE: 212-994-7400 MAIL ADDRESS: STREET 1: ICAPITAL ALTERNATIVE INVESTMENTS LLC STREET 2: 60 EAST 42ND STREET, 26TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10165 D/A 1 primary_doc.xml X0708 D/A LIVE 0002085092 Janus Henderson Biotech Innovation Fund II Access LLC C/O COMPLIANCE DEPARTMENT 60 EAST 42ND STREET, 24TH FLOOR NEW YORK NY NEW YORK 10165 212-994-7400 DELAWARE None None Limited Liability Company true 2025 - Asterion Fund Services, L.L.C. 4001 Kennett Pike Suite 302 Wilmington DE DELAWARE 19807 Promoter Manager of the Issuer - Maples Fiduciary Services (Delaware) Inc. 4001 Kennett Pike Suite 302 Wilmington DE DELAWARE 19807 Executive Officer Managing Member of the Manager of the Issuer ("MFSD Inc.") - iCapital Alternative Investments LLC c/o Compliance Department 60 East 42nd Street, 24th Floor New York NY NEW YORK 10165 Executive Officer Administrator of the Issuer Coleen Gasiewski c/o MFSD Inc. 4001 Kennett Pike, Suite 302 Wilmington DE DELAWARE 19807 Executive Officer Scott Huff c/o MFSD Inc. 4001 Kennett Pike, Suite 302 Wilmington DE DELAWARE 19807 Executive Officer Max Schwartz c/o Compliance Department 60 East 42nd Street, 24th Floor New York NY NEW YORK 10165 Executive Officer Authorized Signatory of the Administrator of the Issuer Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.7 true 0000905148-25-003335 2025-09-01 true true true false 0 Merrill Lynch, Pierce, Fenner & Smith Incorporated 7691 None None One Bryant Park New York NY NEW YORK 10036 All States false Indefinite 155006441 Indefinite false 610 0 true 0 Estimated maximum aggregate sales commission to be paid to the selling agents. The sales commission to be deducted from the subscription amount is up to 2%. 0 false Janus Henderson Biotech Innovation Fund II Access LLC Max Schwartz Max Schwartz Authorized Signatory of the Administrator of the Issuer 2026-10-13